mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours. - Wikidata - awgldk - TriplyDB

mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours.

mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours.

http://www.wikidata.org/entity/Q52899850

about

The PI3K/Akt Pathway in Tumors of Endocrine Tissues Targeting the mTOR signaling pathway in neuroendocrine tumors PI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasms Prognostic significance of AKT/mTOR signaling in advanced neuroendocrine tumors treated with somatostatin analogs.The axon guidance molecule semaphorin 3F is a negative regulator of tumor progression and proliferation in ileal neuroendocrine tumors.(68)Ga-DOTATOC PET and gene expression profile in patients with neuroendocrine carcinomas: strong correlation between PET tracer uptake and gene expression of somatostatin receptor subtype 2 Update on management of midgut neuroendocrine tumors.Prognostic significance of MTOR pathway component expression in neuroendocrine tumors.New therapeutic options for metastatic malignant insulinomas.Translation of molecular pathways into clinical trials of neuroendocrine tumors.Everolimus for the treatment of pancreatic neuroendocrine tumors.Novel molecular targets for the treatment of gastroenteropancreatic endocrine tumors: answers and unsolved problems Biomarkers for predicting future metastasis of human gastrointestinal tumors.The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models.Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis.SOX2 and Rb1 in esophageal small-cell carcinoma: their possible involvement in pathogenesis.Mammalian target of rapamycin signaling activation patterns in pancreatic neuroendocrine tumors.Determination of Mammalian Target of Rapamycin Hyperactivation as Prognostic Factor in Well-Differentiated Neuroendocrine Tumors.Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets.Advances and Current Concepts in the Medical Management of Gastroenteropancreatic Neuroendocrine Neoplasms.Prognostic and predictive role of the PI3K-AKT-mTOR pathway in neuroendocrine neoplasms.The Treatment Landscape and New Opportunities of Molecular Targeted Therapies in Gastroenteropancreatic Neuroendocrine Tumors.Meta-analysis of the prognostic value of p-4EBP1 in human malignancies.The Role of mTOR in Neuroendocrine Tumors: Future Cornerstone of a Winning Strategy?Immunohistochemical evaluation of the mTOR pathway in intra-oral minor salivary gland neoplasms.Regulatory T cells expanded by rapamycin in vitro suppress colitis in an experimental mouse model.

P2860

Q26770404-3C370488-3291-47DE-AA33-84B0FC361046 Q26852089-D9E42173-CB5F-4A69-8FF8-CF7D8F24BC78 Q26862544-4A27039A-08CE-4D96-BA2B-0909D60830B8 Q36447196-D09A304C-398B-4CE2-B175-C5E2777A6053 Q36546773-51B8BFA7-4BDC-4C53-B977-A6F7EBA414D3 Q36568335-EE66B310-BEC4-44B9-B203-CE38CC563C82 Q37025143-CE0EA7F2-3FC1-45ED-B2D5-A90FB08F2F0E Q37165103-93ED6FB9-6177-43AF-BBCA-AD1F973179AD Q37886036-AD5569A9-A3AB-4C5E-A0D4-E67A94C16D67 Q38003074-ADAAAF08-FFAA-4E53-8336-62D1949E3D8C Q38032923-388DA052-5D52-4EF3-AB82-2F422298531B Q38076275-DA2F4DC4-E799-46EE-9118-84526DEF8C58 Q38078237-5E92809D-AC73-4A3B-A83D-A38D56F1CBD3 Q38695102-D5FF3A28-A332-43A3-AFE5-BA9B4956A762 Q38717560-41592588-64A1-4943-ACBE-1D96509C0B9E Q42504523-9022AE65-5B42-47DA-8B4E-A0A3D8DD2692 Q43965111-24C9DA17-94D4-4A68-AF2D-77EB6BB15F7A Q45890813-A7119B62-2404-407E-A068-D11FE7EFA7F0 Q47393972-4A523C08-930C-47B4-A5C9-039EC498BAA4 Q47724538-5523535D-BC32-4D05-9662-35EB80BA28ED Q47847243-BFB90BA0-BDAE-4AE0-AE0F-16A3419E6F04 Q48295398-7F20CE8A-1BBE-44DF-AF65-2D7397433318 Q49515435-647E5732-0191-4A58-97C8-2EB774A08CBA Q54122937-C68A1C73-81EC-40E9-AACF-2BE4E13253AB Q54194644-D77DF995-26EC-4B07-BC2A-220D78A525CE Q54332931-D93013D6-ADA5-4531-97D0-136B9686633A

P2860

mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours.

http://www.wikidata.org/entity/Q52899850

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours.

@en

mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours.

@nl

type

label

mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours.

@en

mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours.

@nl

prefLabel

mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours.

@en

mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours.

@nl

P1433

Q52899850-38A0592B-04E5-4084-BA8A-6F2F585E236E

P1476

Q52899850-D4E48C1D-8467-4F06-88CD-E9E5BAA593EB

P2093

Q52899850-2F8A262A-D33A-4BF0-B908-A1686DCFAF75

Q52899850-66DFDB4D-C044-4EEC-A5CA-CA6C04444BE2

Q52899850-737A81C2-C343-4CFE-8BE3-6FE03D9F9F83

Q52899850-86D07DAA-3BAC-490B-BE31-CFEA65F12AE2

Q52899850-9D098965-49C3-4BC7-AE9D-5F66DA23E32B

Q52899850-A8B6C0D9-4D33-4677-A205-FD9F30FF82AD

Q52899850-D2537DCD-A457-4234-87BD-D30DF1927608

Q52899850-F58311C4-81B6-4491-A77A-4BC63367620B

P304

Q52899850-AF4D8AA3-A42B-4B7E-BE14-E6A0F7DA7081

P31

Q52899850-DF6C9EEB-827E-468A-9ADB-944E8EC84ED3

P356

Q52899850-C92A3A35-99BE-4929-829C-E09C872D00DB

P433

Q52899850-B96CCF4A-9A1F-40C3-9EF0-AB021984028F

P478

Q52899850-801DCD67-A1CF-485F-AB7D-ECF3518B5ED5

P50

Q52899850-DDC1801B-E588-4249-ADE2-A8DAB64D66DC

Q52899850-EB62D044-3B0A-4023-B3B6-B7A3F68D0E35

Q52899850-EBB6CDD7-51A5-4736-B2A6-5A8C3457A4EF

P577

Q52899850-7690C1B4-EC85-4AC4-B283-83F36B1304E1

P698

Q52899850-95EAA805-3CC4-4ECF-B79C-065A01D2755F

P356

P1433

Endocrine-related cancer

P1476

mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours.

@en

P2093

Albrecht Stenzinger

http://www.w3.org/2001/XMLSchema#string

Atsuko Kasajima

http://www.w3.org/2001/XMLSchema#string

Aurelia Noske

http://www.w3.org/2001/XMLSchema#string

Bertram Wiedenmann

http://www.w3.org/2001/XMLSchema#string

Hironobu Sasano

http://www.w3.org/2001/XMLSchema#string

Marianne Pavel

http://www.w3.org/2001/XMLSchema#string

Silvia Darb-Esfahani

http://www.w3.org/2001/XMLSchema#string

Wilko Weichert

http://www.w3.org/2001/XMLSchema#string

P304

181-192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1677/ERC-10-0126

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Carsten Denkert

Christoph Röcken

P577

2011-01-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21159731

http://www.w3.org/2001/XMLSchema#string